Showing 121 - 140 results of 101,272 for search '(( 5 mm decrease ) OR ( 5 ((((step decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.28s Refine Results
  1. 121
  2. 122
  3. 123
  4. 124
  5. 125

    Specific inhibition of ATG5 and ATG7 decrease low glucose-induced LC3-II accumulation. by Delphine Balmer (458897)

    Published 2013
    “…<p>Lentiviruses expressing specific shRNA were used to decrease the expression of ATG5 and ATG7 as described in material & methods, then each clonal cell colony was treated and cultured as mentioned in material & methods. …”
  6. 126
  7. 127
  8. 128
  9. 129

    Impaired Functions of Macrophage from Cystic Fibrosis Patients: CD11b, TLR-5 Decrease and sCD14, Inflammatory Cytokines Increase by Karin Simonin-Le Jeune (464354)

    Published 2013
    “…Furthermore expression of CD11b and TLR-5 were sorely decreased on CF macrophages. Beside, no difference was observed for mCD14, CD16, CD64, TLR-4 and TLR1/TLR-2 expressions. …”
  10. 130
  11. 131
  12. 132

    Supplementary Material for: Longitudinal Decrease in Left Ventricular Size with Age: Impact on Mortality and Cardiovascular Hospitalization by figshare admin karger (2628495)

    Published 2025
    “…Participants were categorized by LVEDD change from baseline: No Change (<5 mm), Decreased (≥5 mm), and Increased (≥5 mm). …”
  13. 133
  14. 134
  15. 135
  16. 136

    Fig 5 - by Ke Lu (124270)

    Published 2022
    Subjects:
  17. 137

    Changes in V<sub>T</sub> and FRC during decreasing PEEP. by Marcus J. Kitchen (444759)

    Published 2014
    “…<p>The increase in tidal volume (V<sub>T</sub>) and decrease in functional residual capacity (FRC) when positive end-expiratory pressure (PEEP) is decreased in 5 cmH<sub>2</sub>O stepwise decrements (10-5-0PEEP), large steps (10-0PEEP) and from a small step (5-0PEEP) in the ventilated lung. …”
  18. 138
  19. 139
  20. 140

    The Immunologic Effects of Mesalamine in Treated HIV-Infected Individuals with Incomplete CD4+ T Cell Recovery: A Randomized Crossover Trial by Ma Somsouk (283498)

    Published 2014
    “…The effect of mesalamine in HIV-infected individuals, who exhibit abnormal mucosal immune activation and microbial translocation (MT), has not been established in a placebo-controlled trial. We randomized 33 HIV-infected subjects with CD4 counts <350 cells/mm<sup>3</sup> and plasma HIV RNA levels <40 copies/ml on antiretroviral therapy (ART) to add mesalamine vs. placebo to their existing regimen for 12 weeks followed by a 12 week crossover to the other arm. …”